BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6415314)

  • 21. Five-year results of a randomized controlled trial of adjuvant chemotherapy for curatively resected colorectal carcinoma. The Colorectal Cancer Chemotherapy Study Group of Japan.
    Jpn J Clin Oncol; 1995 Jun; 25(3):91-103. PubMed ID: 7596054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative clinical study of adjuvant postoperative chemotherapy (5-FU, Tegafur, 5-FU + MMC) in curatively resected cases of gastric cancer. Study Group on 5-FU Oral Adjuvant Chemotherapy in Gastric Cancer].
    Nakajima T; Miwa K; Ohmori Y; Sakabe T; Fujii M; Kajitani T
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1161-8. PubMed ID: 8751804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.
    Di Costanzo F; Gasperoni S; Manzione L; Bisagni G; Labianca R; Bravi S; Cortesi E; Carlini P; Bracci R; Tomao S; Messerini L; Arcangeli A; Torri V; Bilancia D; Floriani I; Tonato M; ; Dinota A; Strafiuso G; Corgna E; Porrozzi S; Boni C; Rondini E; Giunta A; Monzio Compagnoni B; Biagioni F; Cesari M; Fornarini G; Nelli F; Carboni M; Cognetti F; Enzo MR; Piga A; Romiti A; Olivetti A; Masoni L; De Stefanis M; Dalla Mola A; Camera S; Recchia F; De Filippis S; Scipioni L; Zironi S; Luppi G; Italia M; Banducci S; Pisani Leretti A; Massidda B; Ionta MT; Nicolosi A; Canaletti R; Biscottini B; Grigniani F; Di Costanzo F; Rovei R; Croce E; Carroccio R; Gilli G; Cavalli C; Olgiati A; Pandolfi U; Rossetti R; Natalini G; Foa P; Oldani S; Bruno L; Cascinu S; Catalano G; Catalano V; Lungarotti F; Farris A; Sarobba MG; Trignano M; Muscogiuri A; Francavilla F; Figoli F; Leoni M; Papiani G; Orselli G; Antimi M; Bellini V; Cabassi A; Contu A; Pazzola A; Frignano M; Lastraioli E; Saggese M; Bianchini D; Antonuzzo L; Mela M; Camisa R
    J Natl Cancer Inst; 2008 Mar; 100(6):388-98. PubMed ID: 18334706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preoperative cancer chemotherapy for gastric cancer].
    Fujimoto S; Miyazaki M; Endoh F; Shimura T; Sugasawa H; Takahashi O; Kawata S; Kurihara M; Ohta M; Udagawa I
    Gan To Kagaku Ryoho; 1985 May; 12(5):1010-8. PubMed ID: 3922306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adjuvant therapy of gastric cancer in the literature from 1980-1984].
    Iwanaga T; Furukawa H
    Gan To Kagaku Ryoho; 1986 May; 13(5):1962-9. PubMed ID: 3085597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a randomized controlled trial.
    Cascinu S; Labianca R; Barone C; Santoro A; Carnaghi C; Cassano A; Beretta GD; Catalano V; Bertetto O; Barni S; Frontini L; Aitini E; Rota S; Torri V; Floriani I; ; Pozzo C; Rimassa L; Mosconi S; Giordani P; Ardizzoia A; Foa P; Rabbi C; Chiara S; Gasparini G; Nardi M; Mansutti M; Arnoldi E; Piazza E; Cortesi E; Pucci F; Silva RR; Sobrero A; Ravaioli A
    J Natl Cancer Inst; 2007 Apr; 99(8):601-7. PubMed ID: 17440161
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P53 protein expression in gastric adenocarcinoma. Negative predictor of survival after postoperative adjuvant chemotherapy.
    Díez M; Medrano MJ; Gutierrez A; López A; Mugüerza JM; Hernández P; Lozano O; Noguerales F; Ruíz A; Granell J
    Anticancer Res; 2000; 20(5C):3929-33. PubMed ID: 11268479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Immunological approach and surgical treatment of cancer].
    Nakazato H
    Gan No Rinsho; 1983 Oct; 29(13):1537-44. PubMed ID: 6422096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment methods for scirrhous carcinoma of the stomach--with special reference to total gastrectomy and chemotherapy in early postoperative period].
    Nyumura T; Nabeya K; Hamakubo S; Higashino K
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1262-8. PubMed ID: 2837986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A pilot study of the combination of 5-FU and epirubicin for gastric cancer as an adjuvant chemotherapy].
    Tsujinaka T; Ogawa M; Shiozaki H; Kido Y; Murata A; Nishijima J; Kobayashi K; Matsuura N; Mori T
    Gan To Kagaku Ryoho; 1991 May; 18(6):1051-4. PubMed ID: 1903029
    [No Abstract]   [Full Text] [Related]  

  • 31. [Multihospital randomized study on the adjuvant chemotherapy with mitomycin-C and Futraful for gastric cancer V. Estimation of 5-year survival rate].
    Kondo T; Inokuchi K; Hattori T; Inoue K; Taguchi T; Akiyama H; Abe O; Ito I; Nakajima T; Muto T; Kikuchi K; Kasai Y; Sugie S; Hayasaka A
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):2016-24. PubMed ID: 6820887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A gastric cancer patient who underwent curative resection by angiotension-induced hypertension cancer chemotherapy].
    Hakuta Y; Kimura T; Ashizawa I; Sato S; Hara T; Nakazima K
    Gan No Rinsho; 1984 Jan; 30(1):66-9. PubMed ID: 6422102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Randomized study of long-term adjuvant chemotherapy with Futraful and mitomycin C in gastric cancer. A second study (fourth report)].
    Taguchi T; Usugane M; Inokuchi K; Hattori T; Inoue K; Kondo T; Akiyama H; Abe O; Nakajima T; Muto T
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1833-9. PubMed ID: 3929692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Preliminary evaluation of adjuvant chemotherapy against stage Ib or II gastric cancer].
    Inada T; Kawakubo H; Ichikawa A; Ogata Y
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):315-20. PubMed ID: 10065094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Morbidity and mortality of early postoperative intraperitoneal chemotherapy as adjuvant therapy for gastric cancer.
    Yu W; Whang I; Averbach A; Chang D; Sugarbaker PH
    Am Surg; 1998 Nov; 64(11):1104-8. PubMed ID: 9798779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer.
    Chipponi J; Huguier M; Pezet D; Basso N; Hay JM; Quandalle P; Jaeck D; Fagniez PL; Gainant A
    Am J Surg; 2004 Mar; 187(3):440-5. PubMed ID: 15006580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of surgery in the patients with stage I and II primary gastric lymphoma.
    Takahashi I; Maehara Y; Koga T; Sumiyoshi Y; Oshiro T; Baba H; Kohnoe S; Okamura T; Uike N; Matsusaka T; Kume K; Sugimachi K
    Hepatogastroenterology; 2003; 50(51):877-82. PubMed ID: 12828109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of advanced gastric cancer which disappeared histopathologically after short-time chemotherapy].
    Hara K; Yokoyama T; Furuta K; Shinoda M; Yajima K; Yasuda S; Nakazaki S; Kiyomitsu Y; Watanabe K
    Gan No Rinsho; 1984 Apr; 30(4):399-402. PubMed ID: 6727041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The problems of postoperative adjuvant chemotherapy in gastric cancer].
    Kikuchi K; Kunii Y; Kikuchi S
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1136-42. PubMed ID: 3105467
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.
    Yu W
    Eur J Surg Oncol; 2006 Aug; 32(6):655-60. PubMed ID: 16618532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.